CISO Global Books Over $1.1M in CHECKLIGHT Software Sales –
One of the Nation’s Largest Religious Institutions Renews and Expands via a…
Peptinovo Biopharma in Collaboration with Chemelectiva Announces Breakthrough Manufacturing Innovation for Targeted Chemotherapy
First-of-its-kind semi-synthetic vitamin E product enables scalable, FDA-compliant production of Peptinovo’s proprietary…
Tiziana Life Sciences to Ring the Closing Bell at Nasdaq
BOSTON, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA)…
Pathway Healths Lisa Thomson Receives 2026 McKnights Pinnacle Award
LAKE ELMO, Minn., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Pathway Health, a…
Alvotech Launches $100 Million Senior Unsecured Convertible Bond Offering to Continue Strong Investment in R&D, Support Manufacturing, Global Product Launches and Enhance Liquidity Position, reaffirms 2025 outlook and provides 2026 guidance
THIS PRESS RELEASE MAY NOT BE DISTRIBUTED, RELEASED, OR PUBLISHED, DIRECTLY OR…
Bring the Cheer, Pack the Gear: Game On This Holiday Season
LAUSANNE, Switzerland, Dec. 16, 2025 (GLOBE NEWSWIRE) -- As the year winds…
Cholame Finance Academy Finalizes Comprehensive Data Protection Upgrade with Rupert Ellingtons Oversight
Cholame Finance Academy, guided by Rupert Ellington, has completed a comprehensive data…
AB Science announces a new publication on biorxiv that identifies AB8939 as a promising drug candidate for treating refractory acute myeloid leukemia and potentially other cancers
PRESS RELEASE AB SCIENCE ANNOUNCES A NEW PUBLICATION ON BIORXIV THAT IDENTIFIES…
Ipsen completes acquisition of ImCheck Therapeutics, expanding oncology pipeline
PARIS, FRANCE, 15 December 2025 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced…
VivoPower Announces Update to Annual General Meeting
LONDON, Dec. 15, 2025 (GLOBE NEWSWIRE) -- VivoPower International PLC (NASDAQ: VVPR),…